血糖儀市場規模、佔有率和成長分析：按產品類型、糖尿病類型、連接方式、最終用戶和地區分類－產業預測，2026-2033年

2024 年全球血糖儀市值為 312.5 億美元，預計到 2025 年將成長至 353.1 億美元，到 2033 年將成長至 938.6 億美元，在預測期（2026-2033 年）內複合年成長率為 13.0%。

全球血糖儀市場涵蓋血糖儀、試紙和數位平台，這些產品透過及時監測血糖來支持糖尿病管理。糖尿病盛行率的不斷上升影響著全球數百萬人，凸顯了有效控制血糖以避免嚴重併發症的必要性。自從攜帶式設備問世以來，該市場發生了顯著變化，這主要得益於創新的報銷策略和數位技術的融合，這些技術能夠為用戶提供基於血糖數據的可操作性見解。人工智慧的進步使血糖儀能夠提供更高的精度和更直覺的操作體驗。這些技術有助於即時警報和趨勢預測，從而促進糖尿病的預防性管理。因此，製造商正在建立夥伴關係，改善產品以擴大市場覆蓋範圍，提高用戶參與度，並最終增強成長機會。

全球血糖儀市場成長要素

全球糖尿病盛行率的不斷攀升顯著推動了對自我管理解決方案的需求，個人和醫療專業人員都將血糖值。人們對有效疾病管理的日益重視促進了持續監測，最終帶動了血糖儀及相關耗材銷售的成長。為此，製造商正積極拓展銷售管道，並向市場推出更人性化的產品。隨著越來越多的患者尋求可靠的家庭監測解決方案，以幫助他們做出明智的治療決策並改善日常生活中的整體健康狀況，市場成長勢頭進一步增強。

全球血糖儀市場的限制因素

全球血糖儀市場面臨許多挑戰，主要原因是先進血糖儀及其配套一次性試紙高成本。高昂的價格構成了一道巨大的經濟障礙，尤其對於低收入地區和沒有醫療保險的患者而言更是如此。高額的自付費用會降低人們定期進行自我檢測的動機，從而導致對血糖儀及其耗材的需求下降。此外，預算緊張的醫療系統可能會限制對新型血糖儀的保險報銷，進一步阻礙市場滲透。因此，成本敏感度最終限制了市場成長，因為許多潛在使用者更重視經濟因素，而非這些先進檢測方案所帶來的預期臨床效益。

全球血糖儀市場趨勢

全球血糖儀市場正經歷強勁成長，主要得益於數位技術的融合，這些技術能夠提升患者參與度和糖尿病管理的依從性。血糖儀、行動平台和雲端醫療應用的整合推動了藍牙連接和開放式API等技術的進步，從而實現了數據即時傳輸至電子健康記錄和遠端醫療。這種技術協同作用使醫療專業人員能夠快速最佳化治療方案，同時為患者提供自動提醒和個人化趨勢視覺化等功能。因此，連網血糖儀的應用正成為以價值為導向的醫療模式的關鍵要素，並在改善長期健康結果方面發揮重要作用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球血糖機市場規模：依產品類型分類

• 自我血糖儀（SMBG）
• 連續血糖監測（CGM）系統
  • 感應器
  • 發送器和接收器
  • 胰島素幫浦整合
• 瞬時血糖監測系統

全球血糖機市場規模：依糖尿病類型分類

• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病

全球血糖機市場規模：依連接功能分類

• 藍牙相容
• NFC（近距離場通訊）
• 有線（USB）

全球血糖儀市場規模：依最終用戶分類

• 居家照護/自我測量
• 醫院和診所
• 診斷檢查室

全球血糖儀市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories（FreeStyle）
• F. Hoffmann-La Roche Ltd.（Accu-Chek）
• Dexcom Inc.
• Medtronic plc
• Ascensia Diabetes Care Holdings AG
• Omron Healthcare Inc.
• Braun Medical Inc.（B. Braun）
• LifeScan Inc.（Johnson & Johnson）
• BioSig Technologies Inc.
• Senseonics Holdings Inc.
• Agiliti Health Inc.
• NovaBay Pharmaceuticals Inc.
• Ypsomed AG
• AgaMatrix Inc.
• GlucoTrack Inc.
• NovioSense BV
• Qualcomm Life Inc.
• Sinocare Inc.
• Trilogy Medical Ltd.
• Glucose Buddy Inc.

結論與建議

Global Glucometer Market size was valued at USD 31.25 Billion in 2024 and is poised to grow from USD 35.31 Billion in 2025 to USD 93.86 Billion by 2033, growing at a CAGR of 13.0% during the forecast period (2026-2033).

The global glucometer market consists of blood-glucose meters, test strips, and digital platforms that assist individuals in managing diabetes through timely glycemic monitoring. The increasing prevalence of diabetes, affecting millions worldwide, underscores the essential need for effective glucose control to avert serious complications. The market has evolved significantly since the introduction of handheld devices, propelled by innovative reimbursement strategies and the integration of digital technologies that offer users actionable insights from glucose data. With advancements in AI, glucometers now provide enhanced accuracy and intuitive management experiences. These technologies enable real-time alerts and trend predictions, fostering a proactive approach to diabetes care. Consequently, manufacturers are forging partnerships and adapting their products to expand market reach and enhance user engagement, ultimately reinforcing growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glucometer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glucometer Market Segments Analysis

Global glucometer market is segmented by product type, diabetes type, connectivity, end user and region. Based on product type, the market is segmented into Self-Monitoring Blood Glucose (SMBG) Meters, Continuous Glucose Monitoring (CGM) Systems and Flash Glucose Monitoring Systems. Based on diabetes type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes. Based on connectivity, the market is segmented into Bluetooth-Enabled, NFC (Near Field Communication) and Wired (USB). Based on end user, the market is segmented into Homecare / Self-Monitoring, Hospitals & Clinics and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glucometer Market

The increasing prevalence of diabetes worldwide significantly boosts the demand for self-monitoring solutions, leading both individuals and healthcare professionals to embrace glucometers as vital instruments for regular blood glucose monitoring. This growing awareness surrounding effective disease management promotes consistent testing, ultimately enhancing the sales of glucometers and their associated consumables. In response, manufacturers are broadening their distribution channels and launching user-friendly designs, which further propels market growth as more patients look for dependable, at-home monitoring alternatives to aid in therapeutic decision-making and enhance their overall health outcomes in daily routines.

Restraints in the Global Glucometer Market

The Global Glucometer market faces significant challenges primarily due to the high costs associated with advanced glucometers and their corresponding disposable test strips. This premium pricing presents financial barriers, particularly for patients in low-income areas and those without insurance coverage. High out-of-pocket expenses discourage regular self-testing, resulting in diminished demand for both the devices and their consumables. Additionally, healthcare systems burdened by budget limitations may restrict reimbursements for newer models, further hindering their market adoption. Thus, cost sensitivity among potential users ultimately restricts market growth, as many prioritize financial considerations over the perceived clinical advantages of these advanced testing solutions.

Market Trends of the Global Glucometer Market

The Global Glucometer market is witnessing a robust trend driven by the integration of digital technologies that enhance patient engagement and adherence to diabetes management. The convergence of glucometer devices with mobile platforms and cloud-based health applications has led to advancements such as Bluetooth connectivity and open APIs, facilitating real-time data transfer to electronic health records and telemedicine. This technological synergy empowers healthcare providers to optimize therapy adjustments rapidly while offering patients features like automated reminders and personalized trend visualizations. Consequently, the adoption of connected glucometers is becoming pivotal in value-based care models, demonstrating their role in improving long-term health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Glucometer Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Self-Monitoring Blood Glucose (SMBG) Meters
• Continuous Glucose Monitoring (CGM) Systems
  • Sensors
  • Transmitters & Receivers
  • Insulin Pump Integration
• Flash Glucose Monitoring Systems

Global Glucometer Market Size by Diabetes Type & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Global Glucometer Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Bluetooth-Enabled
• NFC (Near Field Communication)
• Wired (USB)

Global Glucometer Market Size by End User & CAGR (2026-2033)

• Market Overview
• Homecare / Self-Monitoring
• Hospitals & Clinics
• Diagnostic Laboratories

Global Glucometer Market Size & CAGR (2026-2033)

• North America (Product Type, Diabetes Type, Connectivity, End User)
  • US
  • Canada
• Europe (Product Type, Diabetes Type, Connectivity, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Diabetes Type, Connectivity, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Diabetes Type, Connectivity, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Diabetes Type, Connectivity, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (FreeStyle)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Accu-Chek)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Medical Inc. (B. Braun)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan Inc. (Johnson & Johnson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSig Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agiliti Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovaBay Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlucoTrack Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NovioSense BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qualcomm Life Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trilogy Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glucose Buddy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations